← FDA Drug Approvals (Drugs@FDA)

SODIUM ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXTROVIS · Approved 2026-04-17

Drug application

FDA Application #

ANDA220274

Application type

Abbreviated New Drug Application (Generic)

Brand name

SODIUM ACETATE

Generic name

Sodium Acetate

Active ingredients

SODIUM ACETATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EXTROVIS

First approval

2026-04-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown